<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>41(6)</volume><submitter>Chen X</submitter><pubmed_abstract>Benign prostatic hyperplasia (BPH) is a common disease that occurs mainly in older men. The pathogenesis of BPH is complex and patients face a prolonged treatment course, and novel drugs with better selectivity and lower toxicity are required. Incaspitolide A (compound TMJ-12) is a germacrane-type sesquiterpenoid compound extracted from the plant Carpesium carnuum. Extracts of C. carnuum are known to exert suppressive effects on BPH-1 cells. In the present study, we investigated the molecular mechanisms underlying the suppressive effect of TMJ-12 specifically on BPH-1 cells. A cytotoxicity assay indicated that TMJ-12 inhibited BPH-1 cell proliferation, while flow cytometry assays showed that TMJ-12 induced G2/M phase cell cycle arrest and the apoptosis of BPH-1 cells. TMJ-12 was also shown</pubmed_abstract><journal>Bioscience reports</journal><pagination>BSR20210477</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8220449</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incaspitolide A extracted from Carpesium cernuum induces apoptosis in vitro via the PI3K/AKT pathway in benign prostatic hyperplasia.</pubmed_title><pmcid>PMC8220449</pmcid><pubmed_authors>Yuan D</pubmed_authors><pubmed_authors>Rao Q</pubmed_authors><pubmed_authors>Jiang K</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Yan C</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Zhu G</pubmed_authors><pubmed_authors>Feng S</pubmed_authors><pubmed_authors>Song J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incaspitolide A extracted from Carpesium cernuum induces apoptosis in vitro via the PI3K/AKT pathway in benign prostatic hyperplasia.</name><description>Benign prostatic hyperplasia (BPH) is a common disease that occurs mainly in older men. The pathogenesis of BPH is complex and patients face a prolonged treatment course, and novel drugs with better selectivity and lower toxicity are required. Incaspitolide A (compound TMJ-12) is a germacrane-type sesquiterpenoid compound extracted from the plant Carpesium carnuum. Extracts of C. carnuum are known to exert suppressive effects on BPH-1 cells. In the present study, we investigated the molecular mechanisms underlying the suppressive effect of TMJ-12 specifically on BPH-1 cells. A cytotoxicity assay indicated that TMJ-12 inhibited BPH-1 cell proliferation, while flow cytometry assays showed that TMJ-12 induced G2/M phase cell cycle arrest and the apoptosis of BPH-1 cells. TMJ-12 was also shown</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2026-05-09T06:40:59.449Z</modification><creation>2022-02-10T18:30:38.167Z</creation></dates><accession>S-EPMC8220449</accession><cross_references><pubmed>34100062</pubmed><doi>10.1042/BSR20210477</doi></cross_references></HashMap>